RxDoctor Payments Data

Robert Allman, MD

Family Medicine · Pendleton, SCNPI 1376804658

Payments from drug & device makers

$800in general payments, 2019–2025

Across 48 payments — averaging $16.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$237
  • Lilly USA, LLC$186
  • Pfizer$88
  • AstraZeneca$72
  • Exact Sciences$48
  • GSK$32
  • plus $137 from 6 others

What the payments were for

  • Food & beverage$800100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$800 in reported general payments places this provider in the 55th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$113,548
Medicare patients
270
Services billed
2,307

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide152$159,695
EliquisApixaban139$110,094
MounjaroTirzepatide52$52,927
Diclofenac Sodium78$29,196
JanuviaSitagliptin Phosphate16$25,168
JardianceEmpagliflozin24$24,347
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$16,004
MyrbetriqMirabegron22$15,566
EntrestoSacubitril/Valsartan16$10,799
SymbicortBudesonide/Formoterol Fumarate25$8,820
Esomeprazole Magnesium120$6,899
TrintellixVortioxetine Hydrobromide12$5,957
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$5,293
Atorvastatin Calcium469$5,031
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen136$3,877

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$237$159,695152 claims
PfizerEliquis$88$110,094139 claims
Lilly USA, LLCMounjaro$186$52,92752 claims
GSKTrelegy Ellipta$32$16,00421 claims
AstraZenecaSymbicort$72$8,82025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Pendleton

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →